Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Debiopharm Innovation Fund is the strategic corporate venture capital arm of Debiopharm, a Swiss biopharmaceutical company. Founded in 2008, the fund invests in companies developing smart data technologies for drug development, digital health, and patient digitization, with a focus on oncology. It provides both capital and strategic guidance to startups aiming to improve the patient journey and transform pharmaceutical R&D.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is Debiopharm Innovation Fund's primary focus as an investor?
- Debiopharm Innovation Fund operates as the venture capital arm of Debiopharm Group, indicating a strategic focus aligned with the parent company's interests.
- Where is Debiopharm Innovation Fund headquartered?
- Debiopharm Innovation Fund is headquartered in Switzerland.
- When was Debiopharm Innovation Fund created?
- Debiopharm Innovation Fund was created on February 9, 2023.
- What type of investor is Debiopharm Innovation Fund?
- Debiopharm Innovation Fund is classified as a corporate venture capital firm.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2008 |
|---|